NYTIMES (Andrew Jacobs) - New Hope for Diagnosing C.T.E. in Brain Injured Patients
Scientists are developing imaging techniques and blood tests that one day may enable doctors to identify the disease definitively in living patients.
Scientists are developing imaging techniques and blood tests that one day may enable doctors to identify the disease definitively in living patients.
On today’s NEWSMAX Israel Update, researchers at Tel Aviv University have developed an experimental blood test designed to identify a chemical fingerprint associated with lung cancer — without requiring expensive DNA sequencing. The research could eventually provide doctors with another tool to complement imaging and monitor patients during treatment. Then, NEWSMAX Israel Correspondent Jodie Cohen heads to Tel Aviv’s Mediterranean shoreline to explore one of the city’s most famous attractions: its beaches. She meets beachgoers enjoying the sand, sea and sunshine and gets a firsthand look at the beach culture that has become an iconic part of life in Tel Aviv.
The Rouche test was developed in collaboration with Eli Lilly and is intended for people 55 years and older with “signs, symptoms, or complaints of cognitive decline.”
It started with just 41 cancer cases, but now, residents in Keyport, New Jersey, say the cases are approaching 400, and they blame a nearby toxic landfill. The state's environmental agency found the presence of harmful toxins in 2010, but didn't find a clear pathway exposing residents. Now, an independent tester found PCBs and dioxins in from samples taken in June 2026. #toxins #cancer #NewJersey
A single infusion of an experimental gene-editing drug seemed to reduce LDL long-term in a small trial. The results may point to something “curative,” one expert said.
Natasha Zouves thought she was doing everything right. Knowing how harmful forever chemicals could be, she avoided nonstick pans, fast food wrappers and products known to contain forever chemicals. And still, her blood test showed PFAS levels above the threshold associated with health risks including cancer. In this clip, Dr. Graham Peaslee explains why forever chemicals stay in the body for years and what you can do about it. Watch this full episode of "The Truth of the Matter": https://youtu.be/-ijOXCsC-fM #PFAs #foreverchemicals #health
If you’re having an unexplained, intense reaction after eating beef or pork, it’s a good idea to seek a blood test.
The tests could help to improve dementia care, but scientists say there are still some caveats and unknowns.
The test can help assess your lifetime risk for cardiovascular disease. That, along with earlier treatment for high cholesterol, is part of new doctors' guidelines.
The test can help assess your lifetime risk for cardiovascular disease. That, along with earlier treatment for high cholesterol, is part of new doctors' guidelines.Open
Until recently, a patient could not receive an Alzheimer’s diagnosis without an expensive scan or invasive procedure. Last year, the FDA cleared two blood-based biomarker tests—or BBB—that require only a routine blood sample for use in diagnosing Alzheimer’s disease. This is an important step forward in Alzheimer’s care, but it won’t mean much to patients unless they are given affordable access to these tests. Right now, federal law prohibits the Medicare program from covering BBB tests without very specific constraints being met, such as a review from the little-known U.S. Preventative Services Task Force or an act of Congress. More than 7 million Americans have Alzheimer’s, and a recent report found that over 90% of…